Vitamin D, B12, and Folate: The Most Over-Ordered and Over-Treated Labs in Primary Care

 

Vitamin D, B12, and Folate: The Most Over-Ordered and Over-Treated Labs in Primary Care

When low B12 is real vs. artifactual, the vitamin D debate that won't die, and why folate deficiency is now almost nonexistent.

These three labs are ordered reflexively on nearly every patient with fatigue, brain fog, or "just to check." And in most cases, the results either don't change management or lead to treatment of a "deficiency" that wasn't real. Let's bring some evidence-based clarity to the most over-ordered panel in primary care.

Vitamin B12

When to Test

Test B12 when there's a clinical reason: macrocytic anemia (MCV >100), peripheral neuropathy, cognitive changes, glossitis, or risk factors for deficiency (strict vegans, pernicious anemia, gastric bypass, metformin use, elderly with poor nutrition, chronic PPI use, Crohn's/celiac affecting the terminal ileum).

The Serum B12 Problem

Serum B12 is a notoriously unreliable test:

• A "low" B12 (200–400 pg/mL) does NOT always mean functional deficiency. Up to 30% of patients with low-normal B12 have no metabolic evidence of deficiency.
• Conversely, some patients with normal serum B12 have functional deficiency at the tissue level.
• Anti-intrinsic factor antibodies can interfere with some B12 assays, causing falsely normal results in pernicious anemia patients who are actually deficient.
• Pregnancy, oral contraceptives, and folate deficiency can all lower serum B12 without true deficiency.

The Confirmatory Test: Methylmalonic Acid (MMA)

MMA is the definitive test for B12 deficiency. B12 is a cofactor for the enzyme that converts methylmalonyl-CoA to succinyl-CoA. When B12 is deficient, MMA accumulates. An elevated MMA confirms functional B12 deficiency regardless of the serum B12 level. Homocysteine is also elevated in B12 deficiency but is less specific (it's also elevated in folate deficiency, hypothyroidism, renal failure, and aging).

The Decision Rule

B12 <200 pg/mL: True deficiency likely. Treat. Check MMA if diagnosis uncertain.
B12 200–400: Gray zone. Check MMA. If MMA elevated, treat. If MMA normal, deficiency is unlikely.
B12 >400: Deficiency excluded in most cases. Don't treat.
Exception: If clinical suspicion is high (neuropathy, macrocytic anemia) regardless of B12 level, check MMA.

Pernicious Anemia Workup

If B12 deficiency is confirmed, determine the cause. Pernicious anemia (autoimmune destruction of parietal cells) is the most important diagnosis to make because it requires lifelong parenteral or high-dose oral B12. Test: anti-intrinsic factor antibodies (highly specific, ~50% sensitive) and anti-parietal cell antibodies (more sensitive but less specific). Pernicious anemia is associated with other autoimmune conditions (autoimmune thyroiditis, vitiligo, type 1 diabetes) and carries an increased risk of gastric carcinoid tumors.

Don't Miss This

B12 deficiency can cause irreversible neurologic damage (subacute combined degeneration of the spinal cord) even without anemia. The neuropathy can precede hematologic changes. If a patient has unexplained neuropathy or gait problems, check B12 and MMA even if the CBC is normal.

Folate

The Short Version: You Almost Never Need to Check It

Since mandatory folic acid fortification of grain products in the US (1998), clinically significant folate deficiency has become rare in the general population. Serum folate is a poor test (it reflects recent dietary intake, not stores) and changes within days of eating folate-rich foods.

When Folate Testing Is Still Relevant

• Macrocytic anemia with normal B12 and normal MMA: Folate deficiency is in the differential (MMA is normal in folate deficiency, which distinguishes it from B12 deficiency; homocysteine is elevated in both).
• Alcohol use disorder: Alcoholism impairs folate absorption and is the most common cause of folate deficiency in developed countries.
• Malabsorption syndromes: Celiac disease, tropical sprue, short bowel syndrome.
• Medications: Methotrexate (folate antagonist), phenytoin, trimethoprim, sulfasalazine.
• Pregnancy: Folate is critical for neural tube closure. However, we supplement with folic acid rather than testing levels.

Clinical Pearl

RBC folate is a better reflection of tissue stores than serum folate (which is too labile). But even RBC folate is now rarely indicated outside of the specific scenarios above. For most primary care patients with fatigue, checking a folate level is not clinically useful.

Danger: Folate Can Mask B12 Deficiency

Giving folate to a patient who actually has B12 deficiency will correct the macrocytic anemia (because folate and B12 share a metabolic pathway for DNA synthesis) but will NOT prevent the neurologic damage of B12 deficiency. Always rule out B12 deficiency before treating macrocytic anemia with folate alone. This is why B12 should be checked first and MMA used to confirm.

Vitamin D

The Ongoing Debate

Vitamin D testing and supplementation is one of the most debated topics in medicine. The evidence has shifted significantly in recent years:

• The USPSTF (2021) found insufficient evidence to recommend screening for vitamin D deficiency in asymptomatic adults.
• The VITAL trial and other large RCTs showed that vitamin D supplementation in unselected adults does not reduce fracture risk, cardiovascular events, or cancer incidence.
• The Endocrine Society (2024) updated guidelines recommending empiric supplementation (1000–2000 IU/day) for certain high-risk groups without routine testing.

The Thresholds

• <12 ng/mL (30 nmol/L): True deficiency. Risk of osteomalacia (adults), rickets (children). Treat.
• 12–20 ng/mL: Insufficiency per some guidelines. Clinical significance debated.
• 20–30 ng/mL: The "gray zone" that generates the most overtesting and overtreatment. The IOM considers 20 ng/mL sufficient for bone health in most people.
• >30 ng/mL: Sufficient by virtually all criteria.
• >50 ng/mL: No proven additional benefit. Risk of toxicity begins above 100 ng/mL.

When to Test Vitamin D

Test When You See

• Osteoporosis or osteomalacia
• Recurrent fractures or unexplained bone pain
• Chronic kidney disease (impaired 1-alpha hydroxylation)
• Malabsorption syndromes (celiac, IBD, short bowel, gastric bypass)
• Medications affecting vitamin D metabolism (anticonvulsants, glucocorticoids, antiretrovirals)
• Hyperparathyroidism workup
• Unexplained hypocalcemia
• Elderly in institutional settings with limited sun exposure

Do NOT Routinely Test

• Asymptomatic adults without risk factors
• "Just to check" as part of a wellness panel
• Patients with fatigue (vitamin D deficiency is very rarely the cause of nonspecific fatigue)

The Pitfalls

• Overtesting asymptomatic patients: Universal vitamin D screening is not recommended and generates a cascade of unnecessary supplementation, retesting, and follow-up.
• Treating "insufficiency" (20–30 ng/mL) aggressively: The evidence for treating levels in this range is weak for most outcomes. Modest supplementation (1000–2000 IU/day) is reasonable for at-risk groups, but high-dose loading protocols for levels of 25 are not evidence-based.
• Checking 1,25-dihydroxyvitamin D instead of 25-hydroxyvitamin D: The correct test for assessing vitamin D status is 25(OH)D. The 1,25(OH)2D test measures the active hormonal form, which is tightly regulated and does NOT reflect stores. It's only indicated in specific scenarios (granulomatous disease, CKD, suspected vitamin D-dependent rickets).
• Vitamin D toxicity from oversupplementation: While rare, it's being seen more often with unregulated high-dose supplementation. Hypercalcemia, nephrocalcinosis, and renal failure can result. Monitor levels if the patient is taking >4000 IU/day.

Quick Reference: When to Test What

Lab	Test When	Don't Test When	Confirm With
B12	Macrocytic anemia, neuropathy, risk factors for deficiency, metformin use	Nonspecific fatigue, "wellness" screening	MMA (elevated = true deficiency)
Folate	Macrocytic anemia with normal B12/MMA, alcoholism, malabsorption, methotrexate use	Routine screening (fortification has made deficiency rare)	RBC folate (better than serum); homocysteine (elevated in both B12 and folate deficiency)
Vitamin D (25-OH)	Osteoporosis, CKD, malabsorption, unexplained bone pain, hyperparathyroidism workup	Asymptomatic adults without risk factors, "just to check," nonspecific fatigue	PTH if hyperparathyroidism suspected; calcium levels

Bottom Line

B12, folate, and vitamin D are important nutrients, but the lab tests for them are overordered, poorly interpreted, and frequently lead to unnecessary treatment. Serum B12 is unreliable in the gray zone—use MMA to confirm. Folate deficiency is now rare and almost never needs checking unless there's macrocytic anemia or specific risk factors. And vitamin D screening in asymptomatic adults is not supported by current evidence—save the test for patients with real risk factors and treat the clinical condition, not the number.

Stay sharp out there.